Pill Test Could Detect 30 Cancer Types
Carnegie Mellon researchers are developing a pill paired with a urine test to screen for up to 30 types of cancer.
Updated on Nov. 18, 2026 in Cancer

Live Poll
Would you use an at-home pill test to screen for cancer each year?
Carnegie Mellon University researchers are developing a pill designed to detect signs of up to 30 types of cancer. The test combines the pill with a urine test and is being built for use as an annual screening tool.
Why it matters
The targeted cancers are most treatable when caught early, so a low-cost, at-home screening option could widen access to detection across the United States. The technology remains in development and has not yet been tested in humans.
The developers are working toward a projected retail price of as little as $100 for a test covering roughly 30 cancer types. Whether the test will perform accurately in people has not yet been established, as human trials have not begun.
The players
Carnegie Mellon University
A private research university in Pittsburgh, Pennsylvania, known for its work in computer science, engineering and biomedical research.
The details
The pill contains engineered biological sensors designed to seek out tumors. If the sensors detect a tumor, they release biological barcodes that pass into urine, which a patient would provide alongside taking the pill. The test is being designed to determine whether cancer is present and potentially to pinpoint its location.
Timeline
Researchers aim to begin human trials within four years.
The test could potentially reach consumers within seven years.
Roadmap
The project reflects a broader push to move multi-cancer detection from laboratory research toward affordable, at-home screening. Its success would depend on whether early-stage sensor designs hold up in the human trials researchers plan to begin within four years.
If the test reaches consumers, it could offer a low-cost, at-home annual screening option that does not require a clinic visit. Until human trials are completed and results are published, readers should continue to rely on established screening recommendations from their doctors.
The takeaway
Early detection matters, and new screening tools in development could make checking for multiple cancers simpler. Readers should treat the pill as a research effort still years from availability and keep up with recommended screenings in the meantime.
Further reading
Explore more cancer news for context on emerging screening research.
Source note: This article includes information reported by WSB-TV Channel 2 - Atlanta.
Live Poll
Would you use an at-home pill test to screen for cancer each year?






